FDA Drug recall D-1389-2012
Lipitor (Atorvastatin calcium)
- FDA Drug
- Class II
- terminated
- Published 2012-06-27
On 2012-06-27 the FDA classified a Class II recall of Lipitor (Atorvastatin calcium) by Physicians Total Care, citing chemical Contamination: Complaints of an uncharacteristic odor identified as 2,4,6 tribromoanisole.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1389-2012 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2012-02-08 |
| Published | 2012-06-27 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Physicians Total Care |
| Distribution | AK, GA, NC |
Product
Lipitor (Atorvastatin calcium); 40 mg, 30 TABLETS, Rx only, Repacked & distributed: Physicians Total Care, Inc., Tulsa OK 74146, NDC 54868-4229-0
Reason
Chemical Contamination: Complaints of an uncharacteristic odor identified as 2,4,6 tribromoanisole.
Identifiers
| code_info | Lots 6284, 60DI, 61AA. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1389-2012%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.